New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
PharmaCielo Ltd.
PCLOF
Shape
US Flag

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

11M

Drug Manufacturers - Specialty & Generic

Next Earning date - 30 Jun 2025

11M

Drug Manufacturers - Specialty & Generic

Next Earning date - 30 Jun 2025

0.06USD

Shape0.02 ( 39.53%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

3617%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

73%
OverviewChart

Quote Panel

Shape
Updated April 27, 2025
1W 34.53 % 1M 51.52 % 3M 3.09 % 1Y -50.82 %

Key Metrics

Shape

  • Market Cap

    10.54M

  • Shares Outstanding

    175.73M

  • Share in Float

    160.20M

  • Dividende

    0

  • Earning Date

    30 Jun 2025

  • Price Target

    0.06

  • Average Volume

    32011

  • Beta

    1.957

  • Range

    0.024-0.22

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Website

    https://www.pharmacielo.com

  • Sector

    Healthcare

Fundamentals

Shape

Relative Strength

Shape

PCLOF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.02
vs -0.02

Q2.23

arrow
arrow

N/A

-0.02
vs -0.02

Q3.23

arrow
arrow

N/A

-0.01
vs -0.03

Q4.23

arrow
arrow

N/A

-0.03
vs -0.01

Q1.24

arrow
arrow

N/A

-0.01
vs -0.02

Q2.24

arrow
arrow

N/A

-0.01
vs -0.02

Q3.24

arrow
arrow

N/A

-0.01
vs -0.01

Q4.24

arrow
arrow

N/A

-0.01
vs -0.03

Q1.25

arrow
arrow

N/A

-0.10
vs -0.01

Q2.25

arrow
arrow

N/A

-0.05
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-35%

786.5K  vs 1.2M

Q2.23

arrow
arrow

-92%

159.5K  vs 2.1M

Q3.23

arrow
arrow

-26%

351.7K  vs 475.3K

Q4.23

arrow
arrow

-84%

244K  vs 1.5M

Q1.24

arrow
arrow

-69%

240.3K  vs 786.5K

Q2.24

arrow
arrow

+391%

783.7K  vs 159.5K

Q3.24

arrow
arrow

+278%

1.3M  vs 351.7K

Q4.24

arrow
arrow

+362%

1.1M  vs 244K

Q1.25

arrow
arrow

+193%

703.7K  vs 240.3K

Q2.25

arrow
arrow

-81%

147.1K  vs 783.7K

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-81%

-0.81
vs -0.66

Q2.23

arrow
arrow

-101%

-1.01
vs -0.81

Q3.23

arrow
arrow

-99%

-0.99
vs -1.01

Q4.23

arrow
arrow

+381%

3.81
vs -0.99

Q1.24

arrow
arrow

+72%

0.72
vs 3.81

Q2.24

arrow
arrow

+47%

0.47
vs 0.72

Q3.24

arrow
arrow

+35%

0.35
vs 0.47

Q4.24

arrow
arrow

+20%

0.2
vs 0.35

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Reports Q4 2024 Financial Results
PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing
PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Reports Q3 2024 Financial Results
PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024
PCLOF

newsfilecorp.com

12 hours ago

PharmaCielo Announces Intention to Extend Expiry Date of Warrants
PCLOF

newsfilecorp.com

16 hours ago

PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024